{
    "organizations": [],
    "uuid": "8e54800f3138cc14c44774ee074c3ab35af6d868",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-intercept-pharma-says-us-court-gra/brief-intercept-pharma-says-u-s-court-granted-defendants-motion-dismissed-with-prejudice-derivative-lawsuit-purportedly-brought-on-behalf-of-company-idUSFWN1R811N",
    "ord_in_thread": 0,
    "title": "BRIEF-Intercept Pharma Says U.S. Court Granted Defendants Motion & Dismissed With Prejudice Derivative Lawsuit Purportedly Brought On Behalf Of Company",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26 (Reuters) - Intercept Pharmaceuticals Inc:\n* INTERCEPT PHARMA - U.S. COURT GRANTED DEFENDANTS MOTION & DISMISSED WITH PREJUDICE DERIVATIVE LAWSUIT PURPORTEDLY BROUGHT ON BEHALF OF COMPANY\n* INTERCEPT PHARMA SAYS LAWSUIT WAS FILED BY A STOCKHOLDER OF CO ON AUG 4, 2017 - SEC FILING Source text: ( bit.ly/2DWMGnS ) Further company coverage:\n ",
    "published": "2018-03-27T05:27:00.000+03:00",
    "crawled": "2018-03-27T11:59:54.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "intercept",
        "pharmaceutical",
        "inc",
        "intercept",
        "pharma",
        "court",
        "granted",
        "defendant",
        "motion",
        "dismissed",
        "prejudice",
        "derivative",
        "lawsuit",
        "purportedly",
        "brought",
        "behalf",
        "company",
        "intercept",
        "pharma",
        "say",
        "lawsuit",
        "filed",
        "stockholder",
        "co",
        "aug",
        "sec",
        "filing",
        "source",
        "text",
        "company",
        "coverage"
    ]
}